Vaxxinity Revenue and Competitors
Estimated Revenue & Valuation
- Vaxxinity's estimated annual revenue is currently $19.2M per year.
- Vaxxinity's estimated revenue per employee is $155,000
Employee Data
- Vaxxinity has 124 Employees.
- Vaxxinity grew their employee count by -7% last year.
Vaxxinity's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Staff | Reveal Email/Phone |
3 | Chief Legal, Compliance & Administrative Officer and Corporate Secretary | Reveal Email/Phone |
4 | VP, Regulatory Affairs & Medical Writing | Reveal Email/Phone |
5 | VP, Regulatory Operations | Reveal Email/Phone |
6 | SVP, Preclinical R&D | Reveal Email/Phone |
7 | SVP, Finance & Accounting | Reveal Email/Phone |
8 | Head Preclinical Development | Reveal Email/Phone |
9 | VP Clinical Operations | Reveal Email/Phone |
10 | VP Finance | Reveal Email/Phone |
Vaxxinity Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Vaxxinity?
Vaccines Against Chronic Diseases
keywords:N/AN/A
Total Funding
124
Number of Employees
$19.2M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vaxxinity News
2022-04-06 - CEPI to co-fund Vaxxinity's pivotal Phase 3 UB-612 ...
CEPI to co-fund Vaxxinity's pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants. April 06, 2022 16:43 ET | Source: Vaxxinity,...
2022-03-22 - Vaxxinity Reports Fourth Quarter and Full-Year 2021 Financial ...
Vaxxinity, Inc. is a purpose-driven biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a...
2022-03-22 - Vaxxinity Announces First Participant Dosed in Phase 3 Study ...
Vaxxinity, Inc. is a purpose-driven biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18M | 124 | 13% | N/A |
#2 | $19.2M | 124 | 39% | N/A |
#3 | $12.4M | 124 | 3% | N/A |
#4 | $33.5M | 124 | 9% | N/A |
#5 | $18.6M | 124 | 11% | N/A |